Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Interlaminar Device Market size was valued at USD 629.19 million in 2024 and is likely to cross USD 1.37 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of interlaminar device is estimated at USD 693.15 million.
The reason behind the growth is the surging rate of minimally invasive spine surgeries. For instance, to treat spinal conditions such as spinal stenosis, an interlaminar device is frequently used to reduce pain and offer the required support to the spine. According to the data published in 2020, more than 300 million surgeries are performed each year.
The growing advancements in spine surgery technologies across the globe are believed to fuel market growth. For instance, newer and safer techniques are being developed which result in shorter stays in hospitals and are known to be more effective.
Global Interlaminar Device Sector: Growth Drivers and Challenges
Growth Drivers
- Upsurge in Diabetes Mellitus Cases- Numerous spine conditions, such as spinal stenosis, spondylolisthesis, and disc herniation, can be brought on by diabetes. These conditions can make it difficult to walk or stand for extended periods because they can induce discomfort in the spine, numbness, and weakness in the legs and back. People with diabetes may experience excessively high blood sugar levels. This can harm blood vessels and nerves all over the body, including the blood vessels and nerves in the spine. Spinal problems may result from injury to these nerves and blood vessels.
- Growing Cases of Sports Injuries – Chronic back pain can be caused by sports injuries which may be treated by interlaminar devices. Therefore, with a surge in the incidence of sports injuries, the market demand is also expected to increase. Approximately 9% of all new cases of spinal cord injuries in the United States are related to sports activities.
- The Presence of Large Medical Equipment Manufacturers-The improvement of the medical facilities and the implementation of innovative health-related initiatives by manufacturers are factors also expected to spur the market expansion. In Poland, for instance, between 2004 and 2020, nearly 14,000 projects related to healthcare were executed.
Challenges
- Unavailability of Proper Healthcare Infrastructure in Underdeveloped Nations - The lack of proper medical facilities is one of the major factors predicted to slow down the market growth. For instance, the unavailability can result in a lack of awareness about interlaminar devices which can lead to delayed treatment in underdeveloped regions.
- Availability of Alternate Treatments
- Lack of Skilled Professionals
Global Interlaminar Device Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.2% |
|
Base Year Market Size (2024) |
USD 629.19 million |
|
Forecast Year Market Size (2037) |
USD 1.37 billion |
|
Regional Scope |
|
Interlaminar Device Segmentation
End-User Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Skilled Nursing Facilities)
The hospitals segment in the interlaminar device market is estimated to gain a robust revenue share in the coming years owing to the increasing spending on hospitals across the globe. Hospitals may be able to invest in advanced interlaminar devices as a result of increased funding. This will also enable access to more resources within hospital premises and will lead to more patients looking for the treatment of chronic pain.
Surgery Type- (Open Surgery, Minimally Invasive Surgery)
The minimally invasive surgery segment is set to garner a notable share shortly on account of rising cases of chronic disorders. Chronic conditions such as chronic pain can be treated with minimally invasive surgery, as it causes less pain and increases the recovery rate, which often involves the use of tools including interlaminar devices, and neurostimulator devices.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Surgery Type |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Interlaminar Device Industry- Regional Synopsis
North American Market Statistics
North America industry is anticipated to account for largest revenue share of 38% by 2037. The market growth in the region is impelled by the rising adoption of interlaminar devices in the region. Countries such as the US, Mexico, and Canada are reported to have rising cases of spinal cord injuries resulting from road traffic accidents, falls, or rising aging populations. For instance, in the U.S., 21.5% of adults were found to include sports and exercise in their daily routines in 2021. Further, this is most likely to rise the demand for the interlaminar device in the area as it is used to stabilize the spine and protect it from any severe damage.
European Market Forecast
The European interlaminar device market is estimated to be the second largest with a share of 26%, during the forecast timeframe. The European market is poised to observe a dominant market for interlaminar devices as a result of better healthcare infrastructure, greater awareness, an improved reimbursement picture, and expanding insurance coverage.
Companies Dominating the Interlaminar Device Landscape
- NuVasive, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zimmer Biomet
- Life Spine, Inc.
- Xtant Medical
- Alphatec Holdings, Inc.
- Amedica Corporation
- Paradigm Health System
- Bioventus LLC
- Medical Device Business Services, Inc.
- Meditech Spine, LLC
Recent Developments
- Xtant Medical introduced Matriform Si designed with Beta-tricalcium phosphate and porcine collagen for spinal fusion. It is a resorbable, osteoconductive product that boosts new bone formation and mechanical stability.
- Bioventus LLC launched SIGNAFUSE Bioactive Bone Graft made up of over 5o% bioglass by weight. Further, the product is in a new strip format that helps patients who need important treatments, such as correcting spinal deformities.
Author Credits: Radhika Pawar
- Report ID: 3974
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Interlaminar Device Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
See our insights in action - schedule your demo now!
